US Patent 10179787 Chemokine receptor modulators and uses thereof
Patent 10179787 was granted and assigned to Flx Bio, Inc. on January, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+122 characters)
Article
Patent abstract
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101797870
Date of Patent
January 15, 2019
0Patent Application Number
156628610
Date Filed
July 28, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101797870
Date of Patent
January 15, 2019
0Patent Application Number
156628610
Date Filed
July 28, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10179787 Chemokine receptor modulators and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10179787
Date of patent
January 15, 2019
Patent application number
15662861
Date Filed
July 28, 2017
Patent primary examiner
Find more entities like US Patent 10179787 Chemokine receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.